Identification | Back Directory | [Name]
CHROMANE-2-CARBOXYLIC ACID | [CAS]
51939-71-0 | [Synonyms]
51939-71-0 IFLAB-BB F2108-0136 Nebivolol Impurity 90 2-Chromancarboxylic Acid Chroman-2-carboxylic acid CHROMANE-2-CARBOXYLIC ACID Chroman-2-carboxylic acid 95+% 3,4-dihydro-2H-chromene-2-carboxylic acid 3,4-Dihydro-1-benzopyran-2-carboxylic acid 3,4-Dihydro-2H-1-benzopyran-2-carboxylic acid 2H-1-BENZOPYRAN-2-CARBOXYLIC ACID, 3,4-DIHYDRO- | [Molecular Formula]
C10H10O3 | [MDL Number]
MFCD00044719 | [MOL File]
51939-71-0.mol | [Molecular Weight]
178.18 |
Chemical Properties | Back Directory | [Melting point ]
99 °C | [Boiling point ]
356.1±31.0 °C(Predicted) | [density ]
1.276±0.06 g/cm3(Predicted) | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
3.09±0.20(Predicted) | [color ]
White | [InChI]
InChI=1S/C10H10O3/c11-10(12)9-6-5-7-3-1-2-4-8(7)13-9/h1-4,9H,5-6H2,(H,11,12) | [InChIKey]
SFLFCQJQOIZMHF-UHFFFAOYSA-N | [SMILES]
C1(C(O)=O)OC2=CC=CC=C2CC1 |
Hazard Information | Back Directory | [Uses]
Chromane-2-carboxylic Acid is used in the synthesis of 4-quinazolinones as Rho kinase inhibitors for application towards glaucoma, hypertension and spinal cord injuries. It is also used in the prepara
tion of chromanyl-benzamidazoles as anti-bacterial compounds. | [Synthesis]
The general procedure for the synthesis of benzodihydropyran-2-carboxylic acid from 4-benzopyrone-2-carboxylic acid is as follows:
Example 20: Synthesis of (±)-benzodihydropyran-2-carboxylic acid
A mixture of the compound obtained in Example 19 (20.0 g, 105 mmol) and activated charcoal-loaded palladium (Pd 10%, 2.0 g) in acetic acid (200 mL) was subjected to a Parr hydrogenation unit and reacted under hydrogen pressure (60 psig). After 22.5 hours of reaction, the mixture was removed from the hydrogen atmosphere and filtered through a diatomaceous earth pad. The diatomaceous earth pad was washed with ethyl acetate (800 mL) and the filtrates were combined and concentrated to give a brown oil. The oil was dissolved in ethyl acetate (500 mL) and extracted with saturated aqueous NaHCO3 (4 x 125 mL). The aqueous phase was acidified with concentrated hydrochloric acid to pH=2 and extracted with ethyl acetate (4 x 100 mL). The organic phases were combined, washed with saturated aqueous sodium chloride solution (100 mL), dried over anhydrous magnesium sulfate and concentrated to give a colorless solid product (18.0 g, 96% yield). The melting point of the product was 97.5-99 °C; 1H NMR (DMSO-d6, 300 MHz) δ 12.96 (br s, 1H), 7.03 (m, 2H), 6.78 (m, 2H), 4.74 (dd, J = 6.4 Hz, 3.9 Hz, 1H), 2.73 (m, 1H), 2.63 (m, 1H), 2.03 (m, 2H ). | [References]
[1] Patent: EP1054881, 2008, B1. Location in patent: Page/Page column 31 [2] Patent: US6469031, 2002, B1 [3] Patent: WO2013/124828, 2013, A1. Location in patent: Page/Page column 48 [4] Patent: US2015/38546, 2015, A1. Location in patent: Paragraph 0355-0356 [5] Patent: EP3239143, 2017, A2. Location in patent: Paragraph 0071 |
|
|